INTRODUCTION
============

Currently, atherosclerosis and its thrombotic complications are still the major cause of morbidity and mortality worldwide \[[@R1]\]. Invasive coronary angiography (ICA) remains the gold standard for the identification of clinically significant coronary stenosis and still remains as the best imaging technique for the diagnosis of obstructive coronary artery disease (CAD) \[[@R2]\]. However, ICA is basically limited to the assessment of the arterial lumen and does not provide information regarding the arterial wall or the presence of subclinical atherosclerosis. Other invasive imaging modalities such as intravascular ultrasound (IVUS) and IVUS-derived techniques allows for the assessment of arterial remodeling, plaque characteristics, and optical coherence tomography allows near-histological resolution of plaque surface, providing detailed anatomical characterization of atherosclerotic plaques \[[@R3]\]. Nevertheless, these invasive techniques are expensive, demonstrate limited availability and, most importantly, are associated with a non-negligible risk of complications. In fact, despite advances in our understanding of the pathophysiology, pathogenesis, and new therapeutic strategies, the absence of an adequate non-invasive imaging tool for early detection limits both the prevention and treatment of patients with various degrees of atherosclerotic CAD.

In recent years, high-resolution magnetic resonance imaging (MRI) has emerged as a very promising technique for studying atherosclerotic disease in humans \[[@R4]-[@R6]\], both *ex-vivo* and *in-vivo*. The emergence of high-resolution, rapid imaging methods has enabled MRI to non-invasively image the fine internal structure of atherosclerotic artery walls. However, it is important to highlight that, so far, the use of MRI for this purpose has been validated mostly in models of carotid or aortic wall atherosclerotic disease \[[@R7]-[@R11]\]. Even though there are several well conducted studies evaluating MRI as a non-invasive tool for the assessment of atherosclerotic CAD \[[@R4],[@R12]-[@R14]\], further pre-clinical experimental validation and evaluation of specific MRI techniques are still needed. Therefore, in the present *ex-vivo* experimental model we sought to determine whether MRI allowed for the morphological characterization of the coronary vessel wall and atherosclerotic plaques using histopathological assessment as the reference standard.

METHODS
=======

Patients
--------

The study population consisted of 13 patients (7 males and 6 females; mean age 68 ± 12 years) who died of acute myocardial infarction and underwent autopsy. All patients had a high-risk profile for atherosclerotic CAD (77% had hypertension, 69% had dyslipidemia, 49% were diabetic, 54% were smokers and 31% former smokers). Informed consent to perform the study was obtained from all families and the protocol was approved by the Institutional Review Board.

Tissue Preparation
------------------

The hearts were fixed with a 10% buffered formalin solution. In order avoid coronary artery collapse during chemical fixation, which could interfere with morphological measurements, we used a dedicated device that performed constant perfusion of the coronary arteries with the formalin solution at a pre-defined perfusion pressure of 80 mmHg during 2 h. After fixation, the proximal portions of the coronary arteries were excised including the surrounding epicardial fat. The excised segments included a portion of the aortic wall encompassing the coronary ostia, the left main coronary artery and at least 3 cm of the left anterior descendent artery (LAD), left circumflex artery (LCX) and right coronary artery (RCA) (Fig. **[1A](#F1){ref-type="fig"}**). Then the arterial segments were evaluated both by MRI and by histopathology.

MR Imaging
----------

All MRI exams were performed on a 1.5T scanner (Signa CV/I, GE Medical Systems, Waukesha, WI). For non-invasive high-resolution imaging, the surface coil for temporomandibular articulation was used for transmission and reception. Before imaging, all arteries were filled with commercial edible soy oil and then were fixed at bottom of a container also filed with soy oil. Localizer images encompassing the entire container were acquired in three orthogonal (axial, sagittal and coronal). Then, all coronary arteries were evaluated using four different 3-dimensional (3D) pulse sequences: 1. 3D fast gradient-echo (3DGRE); 2. 3D fast gradient-echo with fat saturation (FAT SAT 3DGRE); 3. 3D T1-weighted fast spin-echo with fat saturation (FAT SAT 3DFSET1); and 4. 3D T2-weighted fast spin-echo (3DFSET2) (Fig. **[1B](#F1){ref-type="fig"}**-**D**). All four 3D datasets were acquired at the exact same position. The imaging parameters used in the 4 different sequences are detailed in Table **[1](#T1){ref-type="table"}**.

All MR image analyses were performed using the dedicated software package Vitrea 2^®^ (Vital Images, Minnetonka, MM) for reconstruction of curved MPR and short-axis views of the coronary arteries, which were matched to the histological cross-sectional coronary slices. For each arterial segment, the following parameters were calculated through manual planimetry: 1. total vessel area (TVA); 2. lumen area (LA) and 3. plaque area (PA).

Histopathology
--------------

For histopathological assessment, each coronary artery segment was sectioned into sequential transversal 3 mm-slices in order to best match the corresponding MRI slices. Then, for each 3 mm-slice, three paraffin-embedded sections were stained with Verhoeff. Similar to MR image analyses, the following parameters were determined by quantitative video-morphometry using an automated image analysis system (Quantimet 520 Image Analysis System, Cambridge Instruments, Cambridge, UK): 1. total vessel area (TVA); 2. lumen area (LA) and 3. plaque area (PA) (Fig. **[1E](#F1){ref-type="fig"}**).

Statistical Analysis
--------------------

Wilcoxon signed-rank tests were used to compare continuous variables, which were expressed as mean ± SD. Fisher's exact test was used to compare categorical variables. Lin's concordance correlation coefficient (CCC) and Bland-Altman analysis were used to evaluate the agreement between MRI and histopathological coronary artery morphometric measurements \[[@R15]\]. Analyses were performed with Stata software, version 10.0 (StataCorp, College Station, Texas). All tests were 2-tailed and a p\<0.05 was considered significant.

RESULTS
=======

A total of 207 coronary artery cross-sections were found to be suitable for analysis by both MRI and histopathology and were included into the final analyses. The images obtained by all four MRI pulse sequences underwent visual subjective assessment by 2 experienced investigators and those derived from the FAT SAT 3DFSET1 pulse sequence were selected for coronary artery morphometrical measurements. The mean values of TVA, LA and PA measured by MRI and histopathology are summarized in Table **[2](#T2){ref-type="table"}**.

The measurements of TVA by both methods demonstrated moderate to good agreement when we considered all coronary segments (mean difference = 2.4 ± 2.4 mm^2^, 95% limits of agreement from -2.4 to +7.2 mm^2^; CCC = 0.69, 95% confidence interval from 0.63 to 0.75) as well as when we considered each coronary artery separately: LAD (mean difference = 3.1 ± 3.3 mm^2^, 95% limits of agreement from -3.4 to +9.6 mm^2^; CCC = 0.55, 95% confidence interval from 0.40 to 0.71), LCx (mean difference = 2.5 ± 2.0 mm^2^, 95% limits of agreement from -1.4 to +6.4 mm^2^; CCC = 0.69, 95% confidence interval from 0.58 to 0.79) and RCA (mean difference = 2.0 ± 2.1 mm^2^, 95% limits of agreement from -2.1 to +6.2 mm^2^; CCC = 0.69, 95% confidence interval from 0.60 to 0.78) (Table **[3](#T3){ref-type="table"}** and Fig. **[2](#F2){ref-type="fig"}**).

Regarding the measurements of LA both methods also demonstrated good agreement considering the assessment of all coronary segments (mean difference = 0.0 ± 1.7 mm^2^, 95% limits of agreement from -3.3 to +3.3 mm^2^; CCC = 0.84, 95% confidence interval from 0.80 to 0.88) as well as each coronary artery separately: LAD (mean difference = 0.7 ± 2.3 mm^2^, 95% limits of agreement from -3.9 to +5.3 mm^2^; CCC = 0.78, 95% confidence interval from 0.69 to 0.88), LCx (mean difference = -0.7 ± 1.2 mm^2^, 95% limits of agreement from -3.1 to +1.7 mm^2^; CCC = 0.78, 95% confidence interval from 0.70 to 0.87) and RCA (mean difference = 0.1 ± 1.4 mm^2^, 95% limits of agreement from -2.6 to +2.8 mm^2^; CCC = 0.89, 95% confidence interval from 0.86 to 0.93) (Table **[3](#T3){ref-type="table"}** and Fig. **[3](#F3){ref-type="fig"}**).

The agreement between the measurements of PA by both methods was moderate when we considered all coronary segments (mean difference = 2.4 ± 2.4 mm^2^, 95% limits of agreement from -2.3 to +7.1 mm^2^; CCC = 0.64, 95% confidence interval from 0.58 to 0.71) as well as when we considered each coronary artery separately: LAD (mean difference = 2.4 ± 2.8 mm^2^, 95% limits of agreement from -3.1 to +8.0 mm^2^; CCC = 0.65, 95% confidence interval from 0.51 to 0.78), LCX (mean difference = 3.1 ± 2.0 mm^2^, 95% limits of agreement from -0.7 to +7.0 mm^2^; CCC = 0.48, 95% confidence interval from 0.36 to 0.58) and RCA (mean difference = 1.9 ± 2.3 mm^2^, 95% limits of agreement from -2.6 to +6.4 mm^2^; CCC = 0.65, 95% confidence interval from 0.55 to 0.75) (Table **[3](#T3){ref-type="table"}** and Fig. **[4](#F4){ref-type="fig"}**).

DISCUSSION
==========

In the present study we described a novel MRI technique for *ex vivo* coronary artery imaging and were able to demonstrate a moderate to good agreement between the morphometrical measurements obtained with this technique and those derived from specific histopathological analyses. Overall, the degree of agreement was found to be good for the quantification of LA and good to moderate for the assessment of TVA and PA. Importantly, the agreement between both methods was found to be similar for all 3 coronary arteries studied: LAD, LCx and RCA.

Atherosclerosis is the leading cause of morbidity and mortality in industrialized societies, and its incidence is projected to increase in the future \[[@R1]\]. Considering that atherosclerotic disease begins in the vessel wall, the field of cardiovascular imaging is shifting its focus from the assessment of the arterial lumen to imaging of the vessel wall, with the goal of detecting preclinical atherosclerosis. Cardiovascular MRI has been shown to represent a valuable tool for the assessment of various ischemic \[[@R16]-[@R18]\] and non-ischemic cardiomyopathies \[[@R19]-[@R23]\]. Given its high resolution, 3D capabilities, non-invasive nature, absence of ionizing radiation and the capacity for tissue characterization, MRI is emerging as an important modality for the assessment of atherosclerotic plaque burden in different arterial beds, including the carotid arteries, aorta, and more recently, the coronary arteries \[[@R4]-[@R6]\].

Previous studies have evaluated the value of MRI for the assessment of atherosclerotic disease, both *ex vivo* and *in vivo* \[[@R8]-[@R14]\]. Most of these studies have evaluated atherosclerotic plaques in larger vessels, such as the aortic wall or the carotid artery. Yuan *et al.* have performed extensive validation work on the carotid plaques \[[@R10],[@R24]\]. They were the first to investigate the accuracy of arterial wall measurement using carotid high-resolution MRI in patients scheduled for endarterectomy. They performed both *in vivo* and *ex vivo* analyses and demonstrated a high degree of agreement of vessel wall area measurements \[[@R10]\]. They concluded that MRI enables accurate quantitative assessment of vessel wall area in atherosclerotic carotid lesions.

There has been also extensive work evaluating the aortic wall. Fayad *et al.* assessed atherosclerotic plaques in the thoracic aorta both by MRI and by transoesophageal echocardiography \[[@R11]\]. They were able to demonstrate a strong degree of concordance between both methods for plaque composition, mean maximum plaque thickness and overall aortic plaque extent. Steen *et al.* have also published very interesting studies evaluating the characterization of atherosclerotic disease in the aortic wall \[[@R8],[@R9],[@R25]\]. Using an experimental model of combined transoesophageal and surface MRI they managed to generate high quality aortic wall images and achieved a very good degree of reproducibility of aortic wall and atherosclerotic plaque measurements \[[@R9]\]. It is important to recognize that these previous studies have reported values of accuracy and reproducibility of atherosclerosis assessment that are better than the results of the present study. However, these previous studies evaluated much larger and accessible vessels. In contrast, in the present study we evaluated small coronary artery segments in a complex *ex-vivo* model that allowed us to compare with a specific histopathology protocol that included pressurized lumen fixation as the reference standard.

Indeed, the ultimate goal of non-invasive atherosclerosis assessment is the evaluation and characterization of coronary artery atherosclerotic plaques. Worthley *et al.* were the first to report on the feasibility of MR imaging and characterizing of atherosclerotic lesions from *in situ*coronary arteries and aortas in an *ex vivo* porcine model \[[@R26]\]. They also validated MRI measurements using histopathology as the reference standard. They were able to demonstrate very good agreement between MRI and histopathology measurements. In humans, validation was initially performed *ex vivo* using histological specimens. In an elegant study, Toussaint *et al.* used high-field MR spectroscopy to characterize coronary atherosclerotic plaques \[[@R27]\]. Using a combination of T1 weighted and T2w sequences they were able to perform the *in vitro* identification of the atheromatous core, collagenous cap, calcifications, media, adventitia and perivascular fat. These previous reports are in agreement with the results of the present study. We were also able to find, using a novel *ex vivo* coronary imaging, a good agreement between the non-invasive assessment of coronary artery morphology by MRI and the results obtained by the reference standard histopathological analyses.

Autopsy specimens may carry important pathophysiological information on the disease process, particularly, on coronary artery disease, some of them hard to tackle by destructive pathological techniques. *Ex vivo* studies of human coronary arteries by MRI are not common and techniques developed to optimize high spatial resolution images at the pathological level are needed to further explore this technique. The imaging techniques developed on this study might help researchers to investigate more efficiently coronary artery specimens through plaque tissue characterization and morphological determination of the vessel in a variety of disease processes. Even though this is an experimental *ex vivo* study, we believe our results might represent an early step in research that could lead to significant clinical implications in the future. As previously mentioned, we were able to demonstrate that MRI is capable of characterizing atherosclerotic plaques in excised coronary artery segments. However, it is much more difficult to acquire high quality images of the coronary arteries in a clinical model, due to the constant movement of the heart. Nevertheless, there have been important technological advances in the field of cardiac MRI over the past 20 years, especially in the last few years, which have witnessed an even more accelerated technological progression. Thus, it is possible that we might be able, in the near future, to replicate the MRI techniques used in the present study in the clinical scenario. Then, we would be able to characterize the atherosclerotic plaques of patients with suspected CAD non-invasively, possibly optimizing the risk-stratification of these patients through the identification of vulnerable plaques \[[@R28]\]. Undoubtedly, future studies will be necessary to investigate this possibility.

The present study has several limitations. It is not possible to exclude the possibility that the excision of arteries and fixation with formalin might have had some influence on the measurements. Infact, we believe that morphological changes caused by postmortem shrinkage and fixation techniques might have resulted in overestimation of obstructive lesions and could explain, at least in part, the variance between MRI and histopathology measurements \[[@R29]\]. The ratio diameter of lesion-to-residual lumen can be significantly altered by postmortem changes. For this ratio to change, one would have to assume that following fixation the arterial wall shrank while the atherosclerotic material remained unchanged. On the other hand, atherosclerotic deposits are often eccentric and are not necessarily rigid or calcified. Distension of the artery *in vitro* by injection of saline solution or soy oil may mask luminal narrowing to some degree, and thus contribute to "underestimation" of lesions. In addition, distension of the artery *in vitro* or *in vivo* by injection of contrast or solution, or *in vivo* by the blood pressure itself may mask luminal narrowing to some degree, and thus contribute to underestimation of lesions. Finally, the registration of MR cross-sectional images and the corresponding histopathological slices might not have been sufficiently accurate in some arterial segments. Since only a small degree of misalignment could have a significant influence on the degree of agreement between both methods, we believe this potential limitation might have caused an underestimation of the capacity of MRI to accurately characterize coronary artery morphology when compared to histopathology.

CONCLUSION
==========

In recent years, MRI has emerged as one of the most promising techniques for the detailed assessment of atherosclerotic disease. In the present study we were able to demonstrate good agreement between coronary artery morphometrical measurements obtained by high-resolution MRI and by histopathology in an *ex vivo* experimental model. Further studies will be necessary to investigate whether the techniques described in the present study could be used for a more detailed characterization of atherosclerotic disease, including the assessment of the lipid core, the collagenous cap and the degree of positive remodeling.
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![A. Illustrative image demonstrating an example of excised coronary artery segments. B-D. Representative MR images: localizer image used to identify coronary arterial segments (B); High-resolution MR image acquired using the 3D fast gradient-echo with fat saturation pulse sequence (C); High-resolution MR images acquired using the 3D T1-weighted fast spin-echo with fat saturation (FAT SAT 3DFSET1) illustrating the quantitative assessment of coronary arterial segments (D). E. Illustrative image demonstrating histopathological assessment by quantitative video-morphometry using an automated image analysis system.](TOCMJ-8-26_F1){#F1}

![Bland-Altman graphs illustrating the agreement between total vessel area (TVA) measurements by MRI and histopathology for all coronary artery segments (large graph on top) and for each coronary artery separately (small graphs on bottom). TVA indicates total vessel area; LDA, left anterior descending coronary artery; LCx, left circumflex coronary artery; and RCA, right coronary artery.](TOCMJ-8-26_F2){#F2}

![Bland-Altman graphs illustrating the agreement between lumen area (LA) measurements by MRI and histopathology for all coronary artery segments (large graph on top) and for each coronary artery separately (small graphs on bottom). LA indicates lumen area; LDA, left anterior descending coronary artery; LCx, left circumflex coronary artery; and RCA, right coronary artery.](TOCMJ-8-26_F3){#F3}

![Bland-Altman graphs illustrating the agreement between plaque area (PA) measurements by MRI and histopathology for all coronary artery segments (large graph on top) and for each coronary artery separately (small graphs on bottom). PA indicates plaque area; LDA, left anterior descending coronary artery; LCx, left circumflex coronary artery; and RCA, right coronary artery.](TOCMJ-8-26_F4){#F4}

###### 

MR imaging parameters used in the 4 different pulse sequences used.

                               3DGRE      FAT SAT 3DGRE   FAT SAT 3DFSET1   3DFSET2
  ---------------------------- ---------- --------------- ----------------- -----------
  **TR (ms)**                  40         40              600               2300
  **TE (ms)**                  9          9               22                55
  **Flip angle (°)**           50         50              90                90
  **Matrix**                   256x160    256x256         256x256           128x128
  **Reconstructed matrix**     512x256    512x512         512x512           256x256
  **FOV (cm)**                 8          8               8                 8
  **Slice thickness units?**   2          2               2                 4
  **Number of slices**         34         34              34                18
  **NEX**                      1.5        2               1                 1
  **Pixel size (mm)**          0.31x0.5   0.31x0.31       0.31x0.31         0.62x0.62

TR indicates repetition time; TE, echo time; FOV, field-of-view; 3DGRE, 3-dimensional fast gradient-echo; FAT SAT 3DGRE, 3-dimensional fast gradient-echo with fat saturation; FAT SAT 3DFSET1, 3-dimensional T1-weighted fast spin-echo with fat saturation; and 3DFSET2, 3-dimensional T2-weighted fast spin-echo.

###### 

Coronary artery morphometrical measurements by MRI and by histopathology.

                    N     Median (Interquartile Range)   P                
  ----------------- ----- ------------------------------ ---------------- ---------
  ** **                   MRI                            Histopathology    
  **All vessels**   207                                                    
  **TVA (mm^2^)**         14 (11-17)                     12 (9-15)        \<0.001
  **LA (mm^2^)**          4 (2-6)                        4 (3-6)          0.44
  **PA (mm^2^)**          10 (7-11)                      7 (4-9)          \<0.001
  **LAD**           50                                                     
  **TVA (mm^2^)**         17 (14-18)                     12 (10-16)       \<0.001
  **LA (mm^2^)**          4 (0-7)                        4 (0-6)          0.13
  **PA (mm^2^)**          11 (9-13)                      8 (5-13)         \<0.001
  **LCx**           63                                                     
  **TVA (mm^2^)**         11 (9-16)                      8 (7-12)         \<0.001
  **LA (mm^2^)**          4 (2-5)                        4 (3-6)          \<0.001
  **PA (mm^2^)**          8 (5-11)                       5 (2-7)          \<0.001
  **RCA**           94                                                     
  **TVA (mm^2^)**         14 (12-17)                     13 (10-15)       \<0.001
  **LA (mm^2^)**          5 (3-7)                        5 (3-7)          0.28
  **PA (mm^2^)**          10 (7-11)                      7 (5-10)         \<0.001

TVA indicates total vessel area; LA, lumen area; PA, plaque area; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; RCA, right coronary artery; and MRI, magnetic resonance imaging.

###### 

Assessment of agreement between MRI and histopathological measurements.

                    Mean difference (mm^2^)   95% Limits of agreement   CCC (95% confidence interval)
  ----------------- ------------------------- ------------------------- -------------------------------
  **All vessels**                                                        
  **TVA (mm^2^)**   2.4 ± 2.4                 -2.4 to +7.2              0.69 (0.63 to 0.75)
  **LA (mm^2^)**    0.0 ± 1.7                 -3.3 to +3.3              0.84 (0.80 to 0.88)
  **PA (mm^2^)**    2.4 ± 2.4                 -2.3 to +7.1              0.64 (0.58 to 0.71)
  **LAD**                                                                
  **TVA (mm^2^)**   3.1 ± 3.3                 -3.4 to +9.6              0.55 (0.40 to 0.71)
  **LA (mm^2^)**    0.7 ± 2.3                 -3.9 to +5.3              0.78 (0.69 to 0.88)
  **PA (mm^2^)**    2.4 ± 2.8                 -3.1 to +8.0              0.65 (0.51 to 0.78)
  **LCx**                                                                
  **TVA (mm^2^)**   2.5 ± 2.0                 -1.4 to +6.4              0.69 (0.58 to 0.79)
  **LA (mm^2^)**    -0.7 ± 1.2                -3.1 to +1.7              0.78 (0.70 to 0.87)
  **PA (mm^2^)**    3.1 ± 2.0                 -0.7 to +7.0              0.48 (0.36 to 0.58)
  **RCA**                                                                
  **TVA (mm^2^)**   2.0 ± 2.1                 -2.1 to +6.2              0.69 (0.60 to 0.78)
  **LA (mm^2^)**    0.1 ± 1.4                 -2.6 to +2.8              0.89 (0.86 to 0.93)
  **PA (mm^2^)**    1.9 ± 2.3                 -2.6 to +6.4              0.65 (0.55 to 0.75)

TVA indicates total vessel area; LA, lumen area; PA, plaque area; LDA, left anterior descending coronary artery; LCx, left circumflex coronary artery; RCA, right coronary artery; and CCC, concordance correlation coefficient.
